Nerivio® —

Complete Migraine Care

Nerivio is the most widely prescribed electroceutical for the treatment of migraine in the United States for adults and adolescents. It is the first and only FDA cleared therapy to utilize Remote Electrical Neuromodulation (REN) to prevent and treat migraine.

See clinical data

How to prescribe Nerivio

prescribe nerivio

Prescribe Nerivio using this form.   Available also via e-prescription*

 

pharmacy fulfill

Forward prescriptions to ProCare Rx

Nerivio delivered home

ProCare Rx will deliver Nerivio directly to your patient

Are you a healthcare provider seeing adolescents?

Get up to date with the latest in treating adolescent migraine

New International Continuing Medical Education (CME) session is now available online: Unmet Needs in Treating Adolescent Migraine, by US pediatric neurologist and headache specialist Dr. Shannon Babineau.

In this one-hour CME, Dr. Babineau reviews the disease state, explains the special unmet needs of young patients, and describes available therapies, including the newest ones.

Explore the CME

1.0 CME credit
No Cost

(Disclosure: this CME was enabled through an education grant from Theranica)

adolescent with migraine at HCP
INDICATIONS FOR USE

Nerivio is indicated for acute and/or preventive treatment of migraine with or without aura in patients 8 years of age or older. It is a prescription use, self administered device for use in the home environment at the onset of migraine headache or aura for acute treatment, or every other day for preventive treatment.

CONTRAINDICATIONS

Nerivio should not be used by people with uncontrolled epilepsy, an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device. Such use could cause electric shock, electrical interference or serious injuries or medical conditions.

IMPORTANT SAFETY INFORMATION

Nerivio has not been evaluated in people with congestive heart failure (CHF), severe cardiac or cerebrovascular disease, for pregnancy, or those under the age of 8. Nerivio should only be applied on the upper arm over dry, healthy skin with normal physical sensation and without any metallic implants or in proximity to cancerous lesions. For full user instructions and safety information, please see the Nerivio User Manual.